Unlocking India’s pharma potential: How the new government scheme empowers manufacturers

Deepak Pahwa, Chairman, Pahwa Group & Managing Director, Bry-Air highlights that in order to produce superior quality products, it is imperative to provide high-quality air, devoid of even the slightest trace of moisture for various stages of pharma processes entailing manufacturing, storage, research, testing, and packaging

The Indian pharma industry is poised to grow at a phenomenal rate. As per the statistics provided by Invest India, the industry is expected to reach a whopping $130 billion market by 2030. Considering that the quality of medicine is essential to achieving optimal health and aiding in the speedy recovery of patients, focusing on curating superior quality medicine can help in a great way to steer the growth of the sector.

Along similar lines, the recently revamped subsidy scheme announced by the government bodes well for driving the technological upgradation of the pharma industry. In compliance with the Good Manufacturing Practices outlined for the pharma industry, the scheme has been initiated with the aim of enhancing the quality and safety of the pharma products manufactured in the country. Contributing to the production of medicines and products that conform to global standards with the help of advanced technologies, it comes with immense potential to empower the manufacturers of the industry.  

Harnessing the benefits of technology allows manufacturers to exercise quality control and drive the efficacy of the entire manufacturing process. This, in turn, ensures that the end products comply with the highest industry standards as outlined by the Food and Drug Administration (FDA). Here, recognising the damaging effect of moisture in pharma manufacturing, industry players leverage technology to the fullest to eliminate any trace of humidity in the process. Understanding that even the slightest presence of moisture in the manufacturing facility can deteriorate the quality of the products, the industry deploys dehumidification technology to address the issue. Moisture comes with the ability to cause organic corrosion by initiating biochemical reactions. It harbors suitable conditions for the proliferation of unwanted microorganisms that can acutely intervene with the accuracy of the products. Therefore, in order to produce superior quality products, it is imperative to provide high-quality air, devoid of even the slightest trace of moisture for various stages of pharma processes entailing manufacturing, storage, research, testing, and packaging. 

To curb the damaging impact of humidity on the industry, adopting dehumidification solutions can help in a great way to curtail the presence of moisture throughout the processes. The technology makes use of desiccant dehumidifiers to constantly maintain RH as low as 1 per cent or even lower during the production, processing, storage, and packaging of the products. It plays an imperative role in maintaining quality throughout the shelf life of the products. 

Failing to achieve stringent environmental conditions can severely oppose the smooth functioning of the various processes. Moisture can make the materials resilient that resist the various grinding and pulverizing operations during the processing level. It can even result in the defying of pneumatic conveying from one source to another as the materials cling to the grinding machine. Likewise, during the tablet processing stage, humidity can lead to lumping and caking of powder, accounting for the failure of tablet processing. In addition to this moisture is also responsible for the rough and translucent coating of tablets. Cumulatively, all the factors can together account for the revocation of the products from the market, severely impeding the growth prospects of the industry. 

Therefore, to expedite the growth of industry, manufacturers should focus more on state-of-the-art manufacturing by making use of advanced and sophisticated technologies. For acing the manufacturing of pharma products, employing energy-efficient and cost-effective dehumidification solutions aids in combating the moisture menace during manufacturing. Deploying P95°x Dehumidifier from Bry-Air brings breakthrough, new-generation desiccant technology to achieve unmatched performance at 95°C against the prevailing norm of 140°C. In the process of maintaining the relative humidity within safe limits, it contributes to energy conservation and sustainability, achieving an unbeatable energy saving of more than 30 per cent.  

Cumulatively, it can be said that installing dehumidification technology can protect the integrity of the pharmaceutical industry and provide the way forward for the growth of the industry by mitigating the risks looming around the sector. With the Indian pharmaceutical industry growing at a rapid rate, advanced dehumidification technology not just provides cost-effective solutions to produce quality products but also helps the sector make strong inroads in the international market.